Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

COVID-19 vaccine? ASX shares to rocket

There is positive news about a COVID-19 vaccine. ASX shares are expected to rocket today.

COVID-19 vaccine

Global media are reporting that a prospective vaccine being developed by Pfizer and BioNTech can prevent over 90% of people from getting COVID-19 according to a preliminary analysis.

The vaccine trial has been tested on 43,500 people across six countries. Thankfully, no safety concerns have been raised in the trial.

This isn’t the end of the matter, it’s just a milestone, there are still different stages to go through. However, the companies involved plan to apply for emergency approval to use the vaccine by the end of the month.

The ‘90% effective’ figure is based on the first 94 volunteers to develop COVID-19, so the effectiveness may change as more people and results are analysed. According to Pfizer and BioNTech, there will be enough data later this month to take the vaccine to regulators.

Even AstraZeneca, one of the other global healthcare giants trying to develop a vaccine said that the Pfizer data is ‘incredibly promising’.

There are still several questions to be answered. Does it give long-term immunity? How will so many vaccines be produced and distributed (as this vaccine apparently needs to be stored in very cold temperatures – minus 80C).

ASX shares to soar

The ASX 200 could soar over 2%, perhaps as much as 3%, when the markets open. There was a strong overnight reaction to the news.

Some of the sectors that have been mostly heavily affected soared higher. The American Airlines Group Inc (NASDAQ: AAL) share price rose 15.2%, the Walt Disney Co (NYSE: DIS) share price grew almost 12% and the Exxon Mobil Corporation (NYSE: XOM) share price went up 12.7%.

So it will be interesting watching the various sectors on the ASX. Some of the businesses that could be likely to surge higher may be Qantas Airways Limited (ASX: QAN), Sydney Airport Holdings Pty Ltd (ASX: SYD), Flight Centre Travel Group Ltd (ASX: FLT), Webjet Limited (ASX: WEB), Woodside Petroleum Limited (ASX: WPL), Santos Ltd (ASX: STO) and perhaps even some property trusts like Scentre Group (ASX: SCG) and DEXUS Property Group (ASX: DXS).

Personally, if I were going to buy into this frenzy, I’d only buy into the ASX growth shares I think have good long term potential, but would benefit from the indirect effects of a vaccine like A2 Milk Company Ltd (ASX: A2M), EML Payments Ltd (ASX: EML) and Tyro Payments Ltd (ASX: TYR).

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.
Skip to content